KEYS vs NRIX · P/E 57, rev $4.98B vs rev $54.5M
Keysight Technologies Inc (KEYS) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the KEYS and NRIX stock pages for the full models.
Not investment advice.